These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 27176211)
21. Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain. Shinoda M; Ogino A; Ozaki N; Urano H; Hironaka K; Yasui M; Sugiura Y J Pain; 2008 Aug; 9(8):687-99. PubMed ID: 18455478 [TBL] [Abstract][Full Text] [Related]
22. Coapplication of lidocaine and the permanently charged sodium channel blocker QX-314 produces a long-lasting nociceptive blockade in rodents. Binshtok AM; Gerner P; Oh SB; Puopolo M; Suzuki S; Roberson DP; Herbert T; Wang CF; Kim D; Chung G; Mitani AA; Wang GK; Bean BP; Woolf CJ Anesthesiology; 2009 Jul; 111(1):127-37. PubMed ID: 19512868 [TBL] [Abstract][Full Text] [Related]
24. Selectively targeting pain in the trigeminal system. Kim HY; Kim K; Li HY; Chung G; Park CK; Kim JS; Jung SJ; Lee MK; Ahn DK; Hwang SJ; Kang Y; Binshtok AM; Bean BP; Woolf CJ; Oh SB Pain; 2010 Jul; 150(1):29-40. PubMed ID: 20236764 [TBL] [Abstract][Full Text] [Related]
25. Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis. Charrua A; Cruz CD; Jansen D; Rozenberg B; Heesakkers J; Cruz F BJU Int; 2015 Mar; 115(3):452-60. PubMed ID: 25041193 [TBL] [Abstract][Full Text] [Related]
27. Pain-enhancing mechanism through interaction between TRPV1 and anoctamin 1 in sensory neurons. Takayama Y; Uta D; Furue H; Tominaga M Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5213-8. PubMed ID: 25848051 [TBL] [Abstract][Full Text] [Related]
28. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain. Li Y; Cai J; Han Y; Xiao X; Meng XL; Su L; Liu FY; Xing GG; Wan Y Eur J Pain; 2014 Jul; 18(6):774-84. PubMed ID: 24827675 [TBL] [Abstract][Full Text] [Related]
29. Preclinical characterization of three transient receptor potential vanilloid receptor 1 antagonists for early use in human intradermal microdose analgesic studies. Sjögren E; Halldin MM; Stålberg O; Sundgren-Andersson AK Eur J Pain; 2018 May; 22(5):889-903. PubMed ID: 29377430 [TBL] [Abstract][Full Text] [Related]
30. Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain. Yamamoto J; Kawamata T; Niiyama Y; Omote K; Namiki A Neuroscience; 2008 Feb; 151(3):843-53. PubMed ID: 18178319 [TBL] [Abstract][Full Text] [Related]
31. Mechanism of capsaicin receptor TRPV1-mediated toxicity in pain-sensing neurons focusing on the effects of Na(+)/Ca(2+) fluxes and the Ca(2+)-binding protein calretinin. Pecze L; Blum W; Schwaller B Biochim Biophys Acta; 2013 Jul; 1833(7):1680-91. PubMed ID: 22982061 [TBL] [Abstract][Full Text] [Related]
33. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord. Zhou HY; Chen SR; Chen H; Pan HL J Pharmacol Exp Ther; 2008 Nov; 327(2):375-82. PubMed ID: 18669865 [TBL] [Abstract][Full Text] [Related]
34. Contribution of TRPV1 to the bradykinin-evoked nociceptive behavior and excitation of cutaneous sensory neurons. Katanosaka K; Banik RK; Giron R; Higashi T; Tominaga M; Mizumura K Neurosci Res; 2008 Nov; 62(3):168-75. PubMed ID: 18789982 [TBL] [Abstract][Full Text] [Related]
35. Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine tolerance. Bao Y; Gao Y; Hou W; Yang L; Kong X; Zheng H; Li C; Hua B Int J Cancer; 2015 Sep; 137(6):1475-83. PubMed ID: 25708385 [TBL] [Abstract][Full Text] [Related]
36. Co-application of lidocaine and QX-572 induces divergent pain behaviours in mice. Shao CJ; Gao Y; Zhao L; Jin D; Wang D; Wang DQ J Pharm Pharmacol; 2015 Sep; 67(9):1272-8. PubMed ID: 25904024 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade. Xu ZZ; Kim YH; Bang S; Zhang Y; Berta T; Wang F; Oh SB; Ji RR Nat Med; 2015 Nov; 21(11):1326-31. PubMed ID: 26479925 [TBL] [Abstract][Full Text] [Related]
38. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903 [TBL] [Abstract][Full Text] [Related]
39. QX-314 inhibits acid-induced activation of esophageal nociceptive C fiber neurons. Hu Y; Yu X; Yu S Neurogastroenterol Motil; 2019 Apr; 31(4):e13543. PubMed ID: 30663188 [TBL] [Abstract][Full Text] [Related]
40. Gold nanorods-based thermosensitive hydrogel produces selective long-lasting regional anesthesia triggered by photothermal activation of Transient Receptor Potential Vanilloid Type-1 channels. Zhou C; Huang J; Yang Q; Li T; Liu J; Qian Z Colloids Surf B Biointerfaces; 2018 Nov; 171():17-23. PubMed ID: 30005286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]